Trust Co. of Vermont decreased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 12.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 855 shares of the company’s stock after selling 119 shares during the quarter. Trust Co. of Vermont’s holdings in Zoetis were worth $169,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD lifted its stake in shares of Zoetis by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after purchasing an additional 3,244,074 shares during the period. Wellington Management Group LLP increased its holdings in Zoetis by 2.5% in the third quarter. Wellington Management Group LLP now owns 12,344,692 shares of the company’s stock valued at $2,147,730,000 after buying an additional 297,044 shares in the last quarter. Capital World Investors lifted its position in shares of Zoetis by 0.6% during the 4th quarter. Capital World Investors now owns 9,064,158 shares of the company’s stock valued at $1,788,988,000 after acquiring an additional 57,798 shares during the period. Northern Trust Corp boosted its stake in shares of Zoetis by 3.3% during the 3rd quarter. Northern Trust Corp now owns 6,143,258 shares of the company’s stock worth $1,068,804,000 after acquiring an additional 196,771 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Zoetis in the 4th quarter worth approximately $980,646,000. Institutional investors and hedge funds own 92.80% of the company’s stock.
Insiders Place Their Bets
In other news, EVP Roxanne Lagano sold 923 shares of the company’s stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $151.17, for a total transaction of $139,529.91. Following the completion of the transaction, the executive vice president now owns 14,800 shares of the company’s stock, valued at approximately $2,237,316. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.16% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
View Our Latest Research Report on ZTS
Zoetis Stock Performance
Shares of NYSE ZTS opened at $170.87 on Tuesday. The company has a 50-day simple moving average of $165.85 and a 200-day simple moving average of $179.50. The company has a debt-to-equity ratio of 1.30, a current ratio of 3.33 and a quick ratio of 1.94. The company has a market cap of $77.97 billion, a PE ratio of 32.92, a price-to-earnings-growth ratio of 2.65 and a beta of 0.89. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92.
Zoetis (NYSE:ZTS – Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.34 by $0.04. Zoetis had a net margin of 27.38% and a return on equity of 50.34%. The firm had revenue of $2.19 billion during the quarter, compared to analysts’ expectations of $2.14 billion. During the same period in the previous year, the company earned $1.31 EPS. Zoetis’s revenue for the quarter was up 9.5% on a year-over-year basis. On average, equities analysts anticipate that Zoetis Inc. will post 5.76 earnings per share for the current year.
Zoetis Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 4th. Investors of record on Thursday, July 18th will be given a dividend of $0.432 per share. The ex-dividend date is Thursday, July 18th. This represents a $1.73 annualized dividend and a yield of 1.01%. Zoetis’s dividend payout ratio (DPR) is presently 33.33%.
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Further Reading
- Five stocks we like better than Zoetis
- What are earnings reports?
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- Investing in Construction Stocks
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- Why is the Ex-Dividend Date Significant to Investors?
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.